Scripps Laboratories, a leading manufacturer of high-quality proteins, antibodies, and critical reagents for in vitro diagnostic (IVD) assay development, announced a major expansion of its product portfolio through a comprehensive antibody development initiative targeting its expanding line of native and recombinant protein biomarkers.
The Verdict
ClassificationUnsure
ConfidenceMedium confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/83f56924-1922-4781-81a7-5528e03cb723)